financetom
Business
financetom
/
Business
/
GE Vernova Insider Sold Shares Worth $2,046,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GE Vernova Insider Sold Shares Worth $2,046,000, According to a Recent SEC Filing
Aug 27, 2025 2:20 PM

05:04 PM EDT, 08/27/2025 (MT Newswires) -- Kenneth Scott Parks, Chief Financial Officer, on August 26, 2025, sold 3,300 shares in GE Vernova ( GEV ) for $2,046,000. Following the Form 4 filing with the SEC, Parks has control over a total of 7,590 common shares of the company, with 7,590 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1996810/000199681025000141/xslF345X05/wk-form4_1756328301.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Twilio Segment Expands AWS Partnership to Drive More Personalized Marketing Campaigns
Twilio Segment Expands AWS Partnership to Drive More Personalized Marketing Campaigns
Dec 2, 2024
10:21 AM EST, 12/02/2024 (MT Newswires) -- Twilio ( TWLO ) said Monday that Twilio Segment has expanded its integration with Amazon.com's ( AMZN ) Amazon Web Services, with Twilio Segment's Linked Audiences beta now publicly available for Amazon Redshift. Linked Audiences will help Amazon Redshift users drive personalized marketing campaigns that can boost engagement, said Twilio Segment President Thomas...
Delcath Gets FDA Clearance for Phase 2 Liver Cancer Trial
Delcath Gets FDA Clearance for Phase 2 Liver Cancer Trial
Dec 2, 2024
10:17 AM EST, 12/02/2024 (MT Newswires) -- Delcath Systems ( DCTH ) said Monday that the US Food and Drug Administration cleared its investigational new drug application for a phase 2 clinical trial of Hapzato, in combination with standard of care, in liver-dominant metastatic colorectal cancer. The trial will evaluate the safety and efficacy of the combination therapy, with a...
What's Going On With Nebius Shares Monday?
What's Going On With Nebius Shares Monday?
Dec 2, 2024
Nebius Group N.V. ( NBIS ) shares are trading higher on Monday after the company announced it entered into a $700 million private placement financing agreement. Here’s what you need to know. What To Know: The private placement aims to advance the company’s previously outlined plans to expand its comprehensive AI infrastructure, featuring large-scale GPU clusters, cloud platforms and developer-focused...
Update: Supermicro Special Committee Finds No Evidence of Fraud; Shares Jump
Update: Supermicro Special Committee Finds No Evidence of Fraud; Shares Jump
Dec 2, 2024
10:19 AM EST, 12/02/2024 (MT Newswires) -- (Updates with additional information in the second and third paragraphs, and latest stock movement in the headline and last paragraph.) Super Micro Computer ( SMCI ) said Monday that an independent special committee found no evidence of misconduct or fraud on the part of management or the board of directors. The committee, formed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved